News
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for ...
16h
Investor's Business Daily on MSNBioNTech ADR Meets 80-Plus Relative Strength Rating Benchmark
BioNTech ADR earns the No. 143 rank among its peers in the Medical-Biomed/Biotech industry group. Aurinia Pharmaceuticals ...
The top executives running the health care industry’s blue-chip companies amassed generational wealth in 2024, even as many ...
COVID-19 activity is rising in much of the country. Data shows overall respiratory virus spread is very low in the U.S. But ...
New members to the Access Advance patent pool and Harvard University coming under fire were also among the top talking points ...
Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.
The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.
Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly ...
Showing that his loyalty to his own anti-vax mentality is greater than his loyalty to Donald Trump, Robert F. Kennedy Jr., ...
Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results